Some interesting prive volume moves on this stock on Friday.Released a preliminary final report for 02/03 on 1st September. Also recently offloaded their unprofitable products division. Looks to have reasonable prospects. Worth keeping an eye on.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025